| Literature DB >> 16372905 |
Ivan Bautmans1, Ellen Van Hees, Jean-Claude Lemper, Tony Mets.
Abstract
BACKGROUND: Fatigue or lack of interest can reduce the feasibility of intensive physical exercise in nursing home residents. Low-volume exercise interventions with similar training effects might be an alternative. The aim of this randomised controlled trial was to investigate the feasibility of Whole Body Vibration (WBV) in institutionalised elderly, and its impact on functional capacity and muscle performance.Entities:
Mesh:
Year: 2005 PMID: 16372905 PMCID: PMC1368976 DOI: 10.1186/1471-2318-5-17
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Progression of WBV exercise program over 6 weeks training.
| Exercise | Duration | Frequency (Hz) | Amplitude (mm) | Rest (sec) a | ||
| Week 1 | Exercise 1 | 2 | 3 × 30 sec | 35 | 2 | 60 |
| 2 × 30 sec each leg | 3, 4 | 1 × 30 sec | 35 | 2 | 60 | |
| Week 2 | Amplitude: 2 mm | 2 | 3 × 30 sec | 35 | 2 | 30–60 |
| Frequency: 30 Hz | 3, 4, 5, 6 | 1 × 30 sec | 35 | 2 | 30–60 | |
| Week 3 | 2 | 3 × 45 sec | 40 | 2 | 30–60 | |
| 3, 4, 5, 6 | 1 × 45 sec | 40 | 2 | 30–60 | ||
| Week 4 | 2 | 3 × 60 sec | 40 | 2 | 30–60 | |
| 3, 4, 5, 6 | 1 × 60 sec | 40 | 2 | 30–60 | ||
| Week 5 | 2 | 3 × 45 sec | 40 | 2 | 30–60 | |
| 3, 4 | 1 × 30 sec | 30 | 5 | 30–60 | ||
| 5, 6 | 1 × 45 sec | 40 | 2 | 30–60 | ||
| Week 6 | 2 | 3 × 45 sec | 40 | 2 | 30–60 | |
| 3, 4 | 2 × 30 sec | 35 | 5 | 30–60 | ||
| 5, 6 | 1 × 45 sec | 40 | 2 | 30–60 | ||
Exercise 1 = Lunge, Exercise 2 = Squat, Exercise 3 = Deep squat, Exercise 4 = Wide stance squat, Exercise 5 = Calves, Exercise 6 = Calves deep (see [30] for detailed description of the exercises). a Amount of rest between each series of exercise.
Participants' characteristics at baseline.
| Initial Randomisation (N = 13) | Reassessed at 6 weeks (N = 10) | ||||
| 5/8 | 4/6 | 4/7 | - | - | |
| 76.6 ± 11.8 | 76.3 ± 9.7 | 78.6 ± 10.4 | .943 | .849 | |
| 63.5 ± 14.3 | 66.7 ± 13.8 | 63.2 ± 21.1 | .898 | .592 | |
| 1.61 ± 0.12 | 1.63 ± 0.09 | 1.63 ± 0.09 | .787 | .987 | |
| 24.3 ± 3.7 | 25.1 ± 3.8 | 25.2 ± 5.5 | .776 | .557 | |
| 0.92 ± 0.09 | 0.92 ± 0.09 | 0.91 ± 0.11 | .459 | .557 | |
| 24.5 ± 6.4 | 25.7 ± 5.6 | 27.1 ± 9.2 | .691 | 1 | |
| 3.2 ± 1.0 | 3.1 ± 1.0 | 2.9 ± 0.8 | .502 | .725 | |
| 5.6 ± 1.7 | 5.8 ± 1.6 | 4.7 ± 1.7 | .227 | .164 | |
| 10/3 | 7/3 | 8/3 | - | - | |
aADL-category according to Katz et al. [13]. Mann-Whitney U Test (exact 2-tailed significance) Control versus WBV+ binitial randomisation creassessed at 6 weeks. Values represent number or mean ± SD.
Participants' functional performance at baseline.
| Initial Randomisation (N = 13) | Reassessed at 6 weeks (N = 10) | ||||
| -20.2 ± 6.2 | -21.0 ± 6.9 | -23.2 ± 9.4 | .061 | .145 | |
| -23.2 ± 16.0 | -23.0 ± 18.3 | -15.9 ± 6.9 | .323 | .667 | |
| 6.3 ± 4.0 | 7.0 ± 4.1 | 8.2 ± 3.1 | .127 | .303 | |
| | 12.8 ± 3.7 | 13.4 ± 3.1 | 13.2 ± 2.6 | .784 | .566 |
| | 9.6 ± 2.7 | 9.9 ± 2.8 | 9.9 ± 2.1 | .891 | .822 |
| | 22.4 ± 5.9 | 23.3 ± 5.6 | 23.1 ± 4.3 | .966 | .665 |
| 17.9 ± 9.3 | 15.3 ± 5.5 | 14.8 ± 6.3 | .399 | .743 | |
| 41.6 ± 19.5 | 43.3 ± 18.9 | 43.3 ± 24.6 | .765 | .545 | |
| | 66.9 ± 74.6 | 55.8 ± 44.6 | 88.5 ± 79.4 | .361 | .387 |
| | 270.0 ± 203.8 | 251.3 ± 141.4 | 375.2 ± 253.8 | .277 | .282 |
| | 108.0 ± 81.5 | 100.5 ± 56.5 | 150.1 ± 101.5 | .277 | .282 |
| | 2693.1 ± 1698.3 | 2755.0 ± 1600.1 | 4070.0 ± 2483.0 | .134 | .173 |
| | 47.1 ± 57.1 | 36.9 ± 32.9 | 68.7 ± 78.6 | .459 | .468 |
| | 204.3 ± 197. 0 | 178.3 ± 148.1 | 312.1 ± 281.3 | .283 | .290 |
| | 123.4 ± 117.4 | 108.0 ± 87.7 | 187.3 ± 168.7 | .339 | .359 |
| | 3885.0 ± 3291.6 | 3553.5 ± 2700.0 | 4872.3 ± 3371.6 | .424 | .426 |
Mann-Whitney U Test (exact 2-tailed significance) Control versus WBV+ ainitial randomisation breassessed at 6 weeks. Values represent mean ± SD.
Change in functional performance.
| -21.0 ± 6.9 | -18.1 ± 8.0 | .031 | .506 | -23.2 ± 9.4 | -19.9 ± 9.7 | .113 | 1 | .817 | .486 | |
| -23.0 ± 18.3 | -21.2 ± 18.4 | .291 | .989 | -15.9 ± 6.9 | -17.6 ± 8.2 | .424 | .178 | .173 | .618 | |
| 7.0 ± 4.1 | 8.8 ± 5.4 | .062 | .252 | 8.2 ± 3.1 | 8.3 ± 4.0 | .844 | .188 | .200 | .637 | |
| | 13.4 ± 3.1 | 13.9 ± 2.5 | .250 | .938 | 13.2 ± 2.6 | 11.8 ± 3.1 | .008 | .001 | .001 | .031 |
| | 9.9 ± 2.8 | 9.5 ± 3.1 | .125 | .031 | 9.9 ± 2.1 | 9.5 ± 2.3 | .063 | 1 | .680 | .700 |
| | 23.3 ± 5.6 | 23.4 ± 5.5 | 1 | .516 | 23.1 ± 4.3 | 21.3 ± 4.9 | .004 | .002 | .001 | .048 |
| 15.3 ± 5.5 | 12.0 ± 3.7 | .008 | .113 | 14.8 ± 6.3 | 14.3 ± 7.1 | .492 | .029 | .075 | .238 | |
| 43.3 ± 18.9 | 44.6 ± 20.8 | .367 | .904 | 43.3 ± 24.6 | 45.6 ± 25.4 | .102 | .973 | .878 | .562 | |
| | 55.8 ± 44.6 | 92.7 ± 83.9 | .006 | .034 | 88.5 ± 79.4 | 119.3 ± 103.0 | .007 | .989 | .661 | .496 |
| | 251.3 ± 141.4 | 397.6 ± 270.5 | .020 | .052 | 375.2 ± 253.8 | 482.4 ± 313.8 | .032 | .523 | .797 | .940 |
| | 100.5 ± 56.5 | 158.1 ± 107.4 | .020 | .064 | 150.1 ± 101.5 | 193.0 ± 125.5 | .032 | .512 | .773 | .962 |
| | 2755.0 ± 1600.1 | 4800 ± 4187.9 | .020 | .078 | 4070.0 ± 2483.0 | 5151.8 ± 2840.8 | .123 | .848 | 1 | .640 |
| | 36.9 ± 32.9 | 62.3 ± 56.0 | .020 | .077 | 68.7 ± 78.6 | 88.4 ± 96.4 | .005 | .987 | .576 | .496 |
| | 178.3 ± 148.1 | 342.8 ± 287.0 | .004 | .027 | 312.1 ± 281.3 | 398.9 ± 334.8 | .005 | .654 | .962 | .819 |
| | 108.0 ± 87.7 | 205.7 ± 172.2 | .010 | .052 | 187.3 ± 168.7 | 239.3 ± 200.9 | .005 | .605 | .915 | .866 |
| | 3553.5 ± 2700.0 | 6373.5 ± 5249.4 | .010 | .027 | 4872.3 ± 3371.6 | 7093.6 ± 5412.1 | .019 | .809 | .867 | .682 |
Wilcoxon Signed Ranks Test (exact 2-tailed significance): awith (N = 12) & without (N = 10) Last Observation Carried Forward approach, bWorst Rank Score analysis (N = 12); Mann-Whitney U Test (exact 2-tailed significance): cN = 21, d Last Observation Carried Forward approach (N = 23), eWorst Rank Score analysis (N = 23).